LENZ Therapeutics received FDA approval for LNZ100, de-risking the investment and justifying a higher fair value estimate near $50 per share. International commercialization agreements and a large U.S ...

In trading, discussions often center on strategies, indicators, or market predictions. Yet behind the numbers lies a quieter factor that often determines whether a system can endure: position sizing.

Sometimes you're faced with a swing trading setup, but the stock is on the volatile side. Do you skip the trade? It's hard to cut losses quickly for stocks that move a lot. But the possible gains are ...

Quantum-Si shows bullish technical signals: trading above its 30-week EMA, strong momentum, positive volume trends, and outperforming the S&P 500 since April. Upcoming earnings are a key catalyst.